Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
Adrenocortical carcinoma (ACC) is a rare, aggressive malignancy that generally conveys a poor prognosis. Currently, surgical resection is considered the lone curative treatment modality. In addition, the low prevalence of ACC has limited effective clinical trial design to develop evidence-based appr...
Main Authors: | Amir H. Lebastchi, John W. Kunstman, Tobias Carling |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2012/234726 |
Similar Items
-
Gene Expression and Regulation in Adrenocortical Tumorigenesis
by: Tobias Carling, et al.
Published: (2012-12-01) -
Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
by: Omair A. Shariq, et al.
Published: (2021-07-01) -
Current management options for recurrent adrenocortical carcinoma
by: Glover AR, et al.
Published: (2013-06-01) -
Surgical Management of Adrenocortical Carcinoma: Current Highlights
by: Giuseppe Cavallaro, et al.
Published: (2021-07-01) -
Current and Emerging Therapeutic Options in Adrenocortical Cancer Treatment
by: Antonio Stigliano, et al.
Published: (2012-01-01)